Found 17 matching trials
GALLANT 8 Tesaglitazar Add-on to Metformin
PHASE3This is a 24-week randomized double-blind, parallel-group, multi-center, pl...
GALLEX 1 - Long Term Extension Study in Patients With Type 2 Diabetes
PHASE3This is a 107-week open-label, multi-center long-term extension study from ...
GALLANT 5 Tesaglitazar Versus Metformin
PHASE3This is a 52-week randomized, double-blind, parallel-group, multi-center, a...
GALLANT 7 Tesaglitazar Add-on to Sulphonylurea
PHASE3This is a 24-week randomized double-blind, parallel-group, multi-center, pl...
GALLANT 4 Tesaglitazar vs. Glibenclamide
PHASE3This is a 52-week randomized, double-blind, parallel-group, multi-center, a...
GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes Mellitus
PHASE3This is a parallel-group, multi-center, long-term extension study from the ...
GALLANT 2 Tesaglitazar vs. Placebo
PHASE3This is a 24-week randomized, double-blind, parallel-group, multi-center, p...
GALLANT 14 Tesaglitazar vs. Metformin and Fenofibrate
PHASE3This is a 24-week study to determine the lipid metabolic effects, safety, a...
ARAMIS: Actions of tesaglitazaR on fAt Metabolism and Insulin Sensitivity
PHASE2This is a 16-week randomized, double-blind, parallel-group, multi-center, p...
GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
PHASE2This is a 12-week randomized, double-blind, multi-center, active-controlled...